JPS585695B2 - Manufacturing method of effervescent tablets - Google Patents
Manufacturing method of effervescent tabletsInfo
- Publication number
- JPS585695B2 JPS585695B2 JP52097657A JP9765777A JPS585695B2 JP S585695 B2 JPS585695 B2 JP S585695B2 JP 52097657 A JP52097657 A JP 52097657A JP 9765777 A JP9765777 A JP 9765777A JP S585695 B2 JPS585695 B2 JP S585695B2
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- tablets
- water
- anhydrous sodium
- sodium sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Cosmetics (AREA)
- Glanulating (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
Description
【発明の詳細な説明】
本発明は、長期間にわたって安定な発泡錠剤の製法に関
するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a process for producing effervescent tablets that are stable over long periods of time.
ここに「発泡錠剤」とは、一般に結晶性有機酸の如き酸
と炭酸アルカリの如きアルカリとを混合して打錠し、水
中に投入すれば、両者が中和して炭酸ガス等のガスを発
生しながら溶解する錠剤のことである。"Effervescent tablets" are generally made into tablets by mixing an acid such as a crystalline organic acid with an alkali such as an alkali carbonate, and when the mixture is poured into water, the two are neutralized and gases such as carbon dioxide are released. This refers to a tablet that dissolves as it develops.
発泡錠剤は医療用経口薬剤、清涼飲料調製用原料の如き
経口用途のみならず、溶剤、洗浄剤、農薬、防錆剤其他
の種々の非経口用途にも有利に使用できるものである。Effervescent tablets can be advantageously used not only for oral purposes such as medical oral drugs and raw materials for preparing soft drinks, but also for various parenteral purposes such as solvents, detergents, agricultural chemicals, and rust preventives.
しかしながら酸と炭酸アルカリとを混合、打錠すれば、
たとえば微量ではあっても水分(湿気)の存在により直
ちに中和反応が起り、数時間または数日間で錠剤は原形
を止めないまでに崩壊し、全く使用不可能な状態になる
ことはよく知られており、専門的にはこれは薬剤の配合
禁忌という用語で表現される。However, if acid and alkali carbonate are mixed and tableted,
For example, it is well known that the presence of even a small amount of water (humidity) immediately causes a neutralization reaction, and within a few hours or days, the tablet disintegrates without retaining its original shape, rendering it completely unusable. Technically, this is expressed in the term contraindication of drug combination.
このような著しい変化を防止するだめに、通常次のよう
な防止策がとられている。In order to prevent such significant changes, the following preventive measures are usually taken.
(1)酸、アルカリの片方または両方をコーティングし
て顆粒状に造粒し、直接接触させないようにして打錠す
る。(1) Coat with one or both of acid and alkali, granulate, and tablet without direct contact.
(2)完全除去が不可能の水分(湿気)を、製品容器中
に乾燥剤を同封して除去しようとする。(2) Water (humidity) that cannot be completely removed is attempted to be removed by enclosing a desiccant in the product container.
(3)完全耐湿容器を使用する。(3) Use a completely moisture-proof container.
(4)錠剤製造操作を、湿度をコントロールした室内で
行なう。(4) The tablet manufacturing operation is performed in a humidity-controlled room.
水分さえに完全に存在しなければ、中和反応は起きない
のであるが、実際には実質的に不可能なことである。If water is completely absent, the neutralization reaction will not occur, but in reality this is virtually impossible.
このように、水溶性発泡錠剤の製造には高度の技術と完
備した製造設備とが今迄必要であった。Thus, the production of water-soluble effervescent tablets has hitherto required advanced technology and complete production equipment.
当然のことながら製品がコスト高になることは避けられ
ない。Naturally, it is inevitable that the product will cost more.
故に医薬品としてのビタミンC剤とか、清涼飲料用の若
干の製品がみかけられる程度であり、過去に数例商品化
されたことがあるだけで、殺菌・防腐剤、防錆剤等の産
業用を含めて現在はほとんど市場にない。Therefore, there are only a few products such as vitamin C preparations used as pharmaceuticals and products for soft drinks, and only a few examples have been commercialized in the past. Currently, there are almost no such products on the market.
本発明は、種々の用途に利用できる発泡錠剤を、簡単か
つ安価に製造する新規方法を提供するものであシ、経口
投与医薬、清涼飲料調製用原料として、あるいは、入浴
剤、洗顔剤のような人体用に、あるいは産業用として、
少量の有効成分を大量の水中に、攪拌することなく溶解
または分散させることができる。The present invention provides a new method for easily and inexpensively manufacturing effervescent tablets that can be used for a variety of purposes, such as oral medicines, raw materials for the preparation of soft drinks, bath additives, facial cleansers, etc. For human use or industrial use,
Small amounts of active ingredients can be dissolved or dispersed in large amounts of water without stirring.
本発明に係る発泡錠剤の製法は、吸湿性を有するが実質
的に非潮解性である水溶性物質(たとえば無水硫酸ナト
リウム)を、錠剤安定剤またはその一部として使用する
ことを特徴とするものである。The method for manufacturing effervescent tablets according to the present invention is characterized in that a hygroscopic but substantially non-deliquescent water-soluble substance (for example, anhydrous sodium sulfate) is used as a tablet stabilizer or a part thereof. It is.
本発明において発泡錠剤安定剤またはその一部として使
用される物質は次の条件をみたすものでなければならな
い:(1)吸湿性を有すること、(2)実質的に非潮解
性であるとべ(3)水溶性であること。The material used as the effervescent tablet stabilizer or part thereof in the present invention must meet the following conditions: (1) be hygroscopic; (2) be substantially non-deliquescent; 3) Be water-soluble.
この条件をみだす物質は多数あシ、そのうちの一部を示
せば次の通りである:無機無水塩たとえば無水硫酸ナト
リウム、無水硫酸マグネシウム;比表面積の大きい多孔
性結晶の形の・・ロゲン化アルカリ、特に塩化ナトリウ
ム(特公昭51−28685号公報)、非潮解性かつ水
溶性の無水糖類、有機酸塩(たとえばクエン酸アルカリ
)等。There are many substances that meet this condition, some of which are as follows: inorganic anhydrous salts such as anhydrous sodium sulfate, anhydrous magnesium sulfate; in the form of porous crystals with a large specific surface area...alkali halides. , especially sodium chloride (Japanese Patent Publication No. 51-28685), non-deliquescent and water-soluble anhydrous saccharides, organic acid salts (for example, alkali citrate), etc.
なお、実質的に無水の物質の他に、低位水和物も一般に
使用できる。Note that in addition to substantially anhydrous substances, lower hydrates can also generally be used.
たとえば、高位水和物の完全脱水生成物のみならず一部
脱水生成物も使用できる。For example, not only fully dehydrated products of higher hydrates but also partially dehydrated products can be used.
本発明は錠剤自身の中に遊離水分を含まなければ安定で
あるという理念を基本としており、次の如き特長がある
。The present invention is based on the idea that the tablet itself is stable unless it contains free water, and has the following features.
第1の特長は、乾燥剤として使用されている無水硫酸ナ
トリウムの如き実質的に潮解しない吸湿性の、かつ、好
ましくは実質的に無水の物質を錠剤中に比較的大量配合
できることである。The first feature is the ability to incorporate relatively large amounts of a substantially non-deliquescent, hygroscopic, and preferably substantially anhydrous material into the tablet, such as anhydrous sodium sulfate, which is used as a desiccant.
第2の特長は、発泡成分である薬剤が広い範囲内から適
宜選択でき、たとえば非経口用錠剤等の場合にはリンゴ
酸、炭酸ナトリウムでさえ使用できることである。The second feature is that the effervescent component drug can be appropriately selected from a wide range; for example, in the case of parenteral tablets, even malic acid and sodium carbonate can be used.
次に、本発明に従って発泡錠剤安定剤として特に非経口
分野等において非常に有利に使用できる実質的に無水の
硫酸ナトリウムについて詳細に説明する。Next, substantially anhydrous sodium sulfate, which can be very advantageously used as an effervescent tablet stabilizer in accordance with the present invention, particularly in the parenteral field, will be explained in detail.
硫酸ナトリウムという物質は吸湿性が大きい割に、吸湿
しても塩化カルシウムのように溶けて流れ出すというこ
とはなく、一方、シリカゲル等と違って不溶性ではなく
、水溶性である。Although the substance sodium sulfate is highly hygroscopic, it does not dissolve and flow out like calcium chloride when it absorbs moisture.On the other hand, unlike silica gel, it is not insoluble but water-soluble.
原料的に国内に豊富で安価であるために乾燥剤其他の目
的に多用されている。Because it is an abundant and inexpensive raw material in Japan, it is widely used as a desiccant and for other purposes.
まだ、含水状態の硫酸ナトリウム(Na2SO4・10
H20)は溶剤用に既に使用されている。Sodium sulfate (Na2SO4・10
H20) is already used as a solvent.
しかしながら、本発明に従って無水物(すなわち実質的
に無水の硫酸ナトリウム)を加えて錠剤の形に圧縮成形
すれば、以下に述べるような顕著な効果が得られること
が此度見出されだのである。However, it has now been discovered that if an anhydride (i.e., substantially anhydrous sodium sulfate) is added and compressed into tablet form in accordance with the present invention, the following remarkable effects can be obtained. .
すなわち、錠剤自身の中に無水硫酸ナトリウムを大量配
合すれば、混合される他種原料中に含まれろ水分と、空
気中に含まれる湿気とがこの無水硫酸ナトリウム自身の
中に直ちに結晶水として吸収され、その結果錠剤は、遊
離水分を含まない乾燥状態に保たれるだめに、前記の如
き中和反応は全く起らず長期間安定であることが確認さ
れた。In other words, if a large amount of anhydrous sodium sulfate is blended into the tablet itself, the moisture contained in other mixed raw materials and the moisture contained in the air will be immediately absorbed into the anhydrous sodium sulfate itself as crystal water. As a result, it was confirmed that as long as the tablets were kept in a dry state without free water, the neutralization reaction described above did not occur at all and they were stable for a long period of time.
錠剤表面に故意に1滴の水を加えても、そのまわりだけ
で中和反応は止まり、錠剤を裸のまま長期間にわたって
室内放置したときでも、これは全く安定である。Even if one drop of water is intentionally added to the surface of the tablet, the neutralization reaction stops only around that area, and the tablet remains completely stable even when left naked indoors for a long period of time.
このような錠剤が空気中の湿気を吸収し続ければいつか
は飽和点に達して水を吸わなくなり、結局形を維持でき
なくなって、約7日間またはそれ以内に崩壊するであろ
うと予想されるかもしれないが、実際には、後記実施例
に記載の如く長期間にわたって全く安定なのである。If such a tablet continues to absorb moisture from the air, one might expect that it would eventually reach a saturation point and stop absorbing water, eventually being unable to maintain its shape and disintegrating within about seven days or less. However, in reality, it is completely stable for a long period of time as described in the Examples below.
この原因として、成程度の量の水分を吸収した時点で或
種の耐湿性の「壁」ができるのではないかと推定される
のである。The reason for this is thought to be that a kind of moisture-resistant "wall" is formed once a certain amount of moisture has been absorbed.
無水硫酸ナトリウム等に代る物質として、無水炭酸ナト
リウムをはじめ色々の物質が考えられるが、既述の3つ
の条件をみたさないものについて行なった試験の結果は
、いずれも安定性、吸湿性、溶解性、価格等の面からみ
て劣ることが確認された。Various substances, including anhydrous sodium carbonate, can be considered as substitutes for anhydrous sodium sulfate, etc., but the results of tests conducted on substances that do not meet the three conditions mentioned above are poor in terms of stability, hygroscopicity, and solubility. It was confirmed that they are inferior in terms of quality, price, etc.
この他、無水硫酸ナトリウムの利点としては、これを多
量加えただめに酸、アルカリの相互接触を少なくする緩
衝作用をも併せ有することである。Another advantage of anhydrous sodium sulfate is that it also has a buffering effect that reduces mutual contact between acid and alkali when added in large amounts.
次に、本発明の第2の特長、すなわち、酸、アルカリ薬
剤を広い範囲から選択できるという特長について詳細に
説明する。Next, the second feature of the present invention, that is, the feature that acid and alkaline chemicals can be selected from a wide range will be explained in detail.
酸性物質としてのリンゴ酸、アルカリ物質としての炭酸
ナトリウムおよびセスキ炭酸ナトリウムは味が悪いだめ
に経口用途には一般に使用されていない。Malic acid as an acidic substance and sodium carbonate and sodium sesquicarbonate as alkaline substances are generally not used for oral purposes due to their poor taste.
これに代る薬剤としては、酒石酸、クエン酸、酸性炭酸
ナトリウム(重曹)等があるが、これらは高価であシ、
しかも錠剤中に配合したときの安定性では、これらの物
質よシもリンゴ酸、炭酸ナトリウム、セスキ炭酸ナトリ
ウムの方が一層効果的なものであることが実験の結果明
らかになっている。Alternative drugs include tartaric acid, citric acid, and acidic sodium carbonate (baking soda), but these are expensive and
Furthermore, experiments have revealed that malic acid, sodium carbonate, and sodium sesquicarbonate are more effective than these substances in terms of stability when incorporated into tablets.
本発明に係る発泡錠剤の製法について説明する。A method for manufacturing effervescent tablets according to the present invention will be explained.
所定の配合処方に従って原料を次々に混合し、打錠する
ことからなる直接法で打錠すれば目的の錠剤が得られる
が、各成分をそれぞれ造粒した後に混合、打錠する間接
法によっても同様な結果が得られる。The desired tablet can be obtained by the direct method, which consists of mixing raw materials one after another according to a predetermined formulation and then compressing the tablets, but it is also possible to obtain the desired tablet by the indirect method, which involves granulating each component individually and then mixing and tableting. Similar results are obtained.
それには酸、アルカリの両方に無水硫酸ナトリウムを加
えるか、まだは無水硫酸ナトリウ4造粒したものを他種
原料全体に混合してもよい。For this purpose, anhydrous sodium sulfate may be added to both the acid and the alkali, or granulated anhydrous sodium sulfate 4 may be mixed with all other raw materials.
無水硫酸ナ}リウムの配合量が比較的少ない場合には(
10%程度)、発泡量は大きく、溶解が早い代りに耐湿
性は多少劣る。When the amount of anhydrous sodium sulfate is relatively small (
(approximately 10%), the amount of foaming is large, and the dissolution is quick, but the moisture resistance is somewhat inferior.
逆に、無水硫酸ナトリウムの配合量がかなり多いときに
は(80%程度)、発泡量は多くなく、溶解に時間がか
かり、不溶残分を残すことがある代りに、耐湿性は勿論
か々り増大する。On the other hand, when the amount of anhydrous sodium sulfate is quite large (approximately 80%), the amount of foaming is not large, it takes time to dissolve, and insoluble residue may remain, but the moisture resistance is of course greatly increased. do.
しだがって、錠剤の用途に応じて無水硫酸ナトリウムの
配合量をたとえば約10−90%の間で適宜増減するの
が有利である。Therefore, it is advantageous to appropriately increase or decrease the amount of anhydrous sodium sulfate, for example, between about 10 and 90%, depending on the intended use of the tablet.
本発明に係る発泡錠剤の特長は次の通りである。The features of the effervescent tablet according to the present invention are as follows.
(1)安定であること。(1) Be stable.
無水硫酸ナトリウムの如き適当な錠剤安定剤を好ましく
は過剰に配合したことにより経時安定性が著しく大きく
なる。Stability over time is significantly increased by incorporating a suitable tablet stabilizer such as anhydrous sodium sulfate, preferably in excess.
特に、成程度吸湿したときの方が一層安定になり、同時
に錠剤の硬度も増す。In particular, when the tablet absorbs moisture to a certain degree, it becomes more stable and at the same time the hardness of the tablet increases.
(2)製造が容易であること。(2) It should be easy to manufacture.
原料を次々に混合し直接法で打錠できる。Raw materials can be mixed one after another and tableted directly.
勿論、顆粒に造料することを含む間接法によっても同じ
、結果が得られる。Of course, the same results can also be obtained by indirect methods involving granulation.
また、製造室内にわざわざ除湿装置を設けることは全も
不必要である。Further, it is unnecessary to take the trouble to provide a dehumidifying device in the manufacturing room.
(3)安価であること。(3) It should be inexpensive.
原料的に国内で豊富で安価であり、安定供給できる。As raw materials, it is abundant and inexpensive domestically and can be supplied stably.
また製造設備投資も節約でき、製品は高価な耐湿容器を
必要としない。Manufacturing equipment investment is also saved, and the product does not require expensive moisture-resistant containers.
(4)便利で使用感がよいこと。(4) Convenience and ease of use.
この錠剤を水中K被入すれば発泡して数分間で透明に溶
ける。When this tablet is immersed in K water, it foams and dissolves transparently in a few minutes.
たとえば後記実施例1に記載の錠剤では、1錠(13f
)より450eCの炭酸ガスを発生し、使用感がよい。For example, in the tablet described in Example 1 below, one tablet (13f
) generates carbon dioxide gas of 450eC and is pleasant to use.
まだ本発明に従えば、直接口中に投与される発泡錠剤状
の菓子、薬品等も製造できる。Still, according to the present invention, effervescent tablet-shaped confectioneries, medicines, etc., which are administered directly into the mouth, can also be produced.
この型式の発泡錠剤はそのまま口中に入れると、日中の
唾液に溶解し発泡して爽快な感じを与える。When this type of effervescent tablet is put into the mouth, it dissolves in saliva during the day and effervesces, giving a refreshing feeling.
農薬等の場合には、粉末のままでは取扱の途中で飛散し
、人畜がこれを吸込んで中毒したり、あるいは周囲を汚
染することがあるが、本発明に従って発泡錠剤に加工し
て使用するときには上記の如き危険は全くない。In the case of pesticides, etc., if they are powdered, they may scatter during handling, causing poisoning to humans and animals by inhaling them, or contaminating the surrounding area. However, when processed into effervescent tablets according to the present invention, There is no danger like the above.
この発泡錠剤の形の農薬は空気中では安定であるだめに
取扱が容易であり、保管中に吸湿して崩壊することは全
くなく、しかも水中に入れたときは速やかに発泡崩壊し
均一に溶解まだは分散して、農薬としての効果を充分に
発揮するものである。This effervescent tablet form of pesticides is stable in the air and easy to handle, and does not absorb moisture and disintegrate during storage. Moreover, when placed in water, it quickly expands and disintegrates, dissolving uniformly. However, it is still dispersed and fully exerts its effect as an agrochemical.
しだがってこの発泡錠剤状農薬は、錠剤の形のままで水
田の水等の中に直接投与でき、安全かつ簡単に農薬散布
が実施できる。Therefore, this effervescent tablet-shaped pesticide can be directly administered into water, etc. of paddy fields in the form of a tablet, and the pesticide can be sprayed safely and easily.
さらに、錠剤1個当りの農薬含有量が一定であるから、
農薬の定量撒布が非常に容易である。Furthermore, since the pesticide content per tablet is constant,
It is very easy to apply a fixed amount of pesticides.
さらにまだ、たとえば噴霧用等液状農薬を現場で作ると
きにも、この発泡錠剤が非常に便利であり、すなわち、
所定の数の錠剤を所定容積の水の中に投入すれば直ちに
発泡溶解して、所定の濃度の噴霧用液剤が簡単に得られ
る。Furthermore, effervescent tablets are very convenient when making liquid pesticides on site, for example for spraying, i.e.
When a predetermined number of tablets are put into a predetermined volume of water, they immediately foam and dissolve, and a sprayable liquid preparation of a predetermined concentration can be easily obtained.
実施例1
入浴剤
無水硫酸ナトリウム 42(%)リンゴ酸
30無水炭酸ナトリウム
25
滑沢剤、離型剤の如き打錠用助剤 適量
着色剤、着香剤 適量
混合槽中に出発成分を入れて混合し、常法により打錠す
る。Example 1 Bath additive anhydrous sodium sulfate 42 (%) malic acid
30 Anhydrous sodium carbonate
25 Tableting aids such as lubricants and release agents Appropriate amounts of coloring agents and flavoring agents Add appropriate amounts of starting ingredients to a mixing tank, mix, and tablet by conventional methods.
できだ錠剤は樹脂フイルムまたはアルミ箔にパックする
かまたは大容器にそのまま入れる。Pack the finished tablets in resin film or aluminum foil, or place them in a large container.
製造室にエアコントロールの設備をしたり、錠剤をさら
に乾燥剤を入れて2重パックする等の操作は全く不必要
である。There is no need to install air control equipment in the manufacturing room or double pack the tablets with a desiccant agent.
この錠剤は、入浴剤としてはありふれた成分のみからな
るものであるようにみえるが、錠剤に加工したことによ
り極めて特異なすぐれた製品が得られるのである。These tablets may seem to consist of only common ingredients for bath additives, but by processing them into tablets, a very unique and superior product is obtained.
この点については、後記試験例の記載を参照されたい。Regarding this point, please refer to the description of the test examples below.
実施例2
洗顔剤
無水硫酸ナトリウム 20(%)リンゴ酸
50セスキ炭酸ナトリウ
ム 25
L−アスコルピン酸 3
滑沢剤等の打錠用の助剤 2
上記組成の出発成分を実施例1の場合と同様な方法に従
って打錠した。Example 2 Facial cleanser anhydrous sodium sulfate 20(%) malic acid
50 Sodium sesquicarbonate 25 L-ascorbic acid 3 Tableting aids such as lubricants 2 The starting components of the above composition were tableted in the same manner as in Example 1.
この錠剤を洗面器の水中に投入すれば30秒位で速やか
に溶解し、酸性はpH約5位である。When this tablet is placed in water in a basin, it dissolves quickly in about 30 seconds, and its acidity is approximately 5th in pH.
実施例3
入浴剤
次の処方に従って発泡錠剤を、実施例1の場合と同様な
製法に従って製造した。Example 3 Bath Salts Effervescent tablets were manufactured according to the following recipe according to the same manufacturing method as in Example 1.
無水硫酸ナトリウム 40(%)酒石酸(
結晶水を実質的に 25
含まないもの)
無水炭酸ナトリウム 30
打錠用助剤、着色剤、着香剤 適量
この発泡錠剤は、実施例1記載の錠剤と同程度にすぐれ
たものであった。Anhydrous sodium sulfate 40 (%) tartaric acid (
Substantially free of water of crystallization (25) Anhydrous sodium carbonate (30) Tableting aids, coloring agents, flavoring agents (appropriate amounts) This effervescent tablet was as good as the tablet described in Example 1.
経時安定性の試験結果(耐湿性)
試験1(高温多湿条件下放置試験)
実施例1記載の錠剤(浴剤)をゆるやかに含み、温度4
5℃、湿度90−100%において14日間保った。Test results of stability over time (humidity resistance) Test 1 (standing test under high temperature and humidity conditions) The tablet (bath agent) described in Example 1 was loosely contained, and the temperature was 4.
It was kept at 5°C and 90-100% humidity for 14 days.
この錠剤は全く変化せず、大きさ等は試験前の場合と同
じであった。This tablet did not change at all, and its size etc. were the same as before the test.
これを温度40℃の湯中に溶解するとき標準品と同量の
450ccの炭酸ガスを発生して透明に溶解した。When this was dissolved in hot water at a temperature of 40°C, 450 cc of carbon dioxide gas, the same amount as the standard product, was generated and the product was dissolved transparently.
一方、対照試料(無水硫酸ナトリウムを配合しなかった
ことを除いて、実施例1記載の発泡錠剤と同じ組成の錠
剤)は、この試験後に調べると体積が約1.5倍に増え
ており、これを水中に投入し基準)にすぎなかった。On the other hand, when the control sample (tablet with the same composition as the effervescent tablet described in Example 1 except that anhydrous sodium sulfate was not added) was examined after this test, the volume had increased by about 1.5 times. This was only used as a standard (after putting it into the water).
試験2
実施例1記載の錠剤を裸にして、梅雨時である6月10
日から室内で放置した。Test 2 The tablets described in Example 1 were stripped and tested on June 10, during the rainy season.
I have left it indoors since then.
180日間経過しだ後においても全く変化が認められな
かった。No change was observed even after 180 days had passed.
一方、無水硫酸ナトリウムを配合しなかった対照試料は
、僅か7日後でさえ、室内の湿気を吸収して膨張し、も
との体積の約2倍になり、崩壊してしまった。On the other hand, the control sample that did not contain anhydrous sodium sulfate absorbed moisture in the room, expanded to about twice its original volume, and collapsed even after only 7 days.
実施例4
かぜ薬の錠剤
次の成分を打錠することにより、発泡性かぜ薬錠剤を得
だ。Example 4 Cold Medicine Tablets Effervescent cold medicine tablets were obtained by compressing the following ingredients into tablets.
アセチルサリチル酸 0.3(g)無水ク
エン酸ナトリウム 0,7無水クエン酸
1.0無水炭酸ナトリウム
0.6ブドウ糖 0.
5人工甘味料・香料等 適量
打錠用助剤 適量
試験3
実施例4により得られた発泡性かぜ薬錠剤を既述の試験
1の方法により試験した。Acetylsalicylic acid 0.3 (g) Anhydrous sodium citrate 0.7 Anhydrous citric acid
1.0 anhydrous sodium carbonate
0.6 Glucose 0.
5 Artificial Sweeteners, Flavorings, etc. Appropriate Amount Tableting Auxiliary Appropriate Amount Test 3 The effervescent cold medicine tablets obtained in Example 4 were tested by the method of Test 1 described above.
これは、放置状態では安定であり、これを水中に投入す
ると、よく発泡溶解した。This was stable when left standing, and when placed in water, it foamed and dissolved well.
一方、対照試料である市販の発泡性かぜ薬錠剤(1錠約
3g)について試験したところ、密封品では耐湿性は全
く変化しないが、裸にして室内に放置したものは室内の
湿気を吸収して炭酸ガスを発生し、毎日1錠当り約0.
1gづつ減量し、5日目になって形がくずれ始め、これ
を水中に入れてもほとんど発泡しなかった。On the other hand, when testing commercially available effervescent cold medicine tablets (approximately 3 g per tablet) as a control sample, it was found that the moisture resistance of the sealed product did not change at all, but the one that was left uncovered indoors absorbed indoor moisture. It generates carbon dioxide gas, and each tablet contains about 0.
The weight was reduced by 1 g, and on the 5th day, the shape started to collapse, and even when it was placed in water, it hardly foamed.
実施例5 清涼飲料用錠剤 下記の成分をよく混合した後、打錠機にて錠剤化した。Example 5 Soft drink tablets After thoroughly mixing the following ingredients, the mixture was made into tablets using a tablet machine.
無水クエン酸ナトリウム 30(%)ブドウ糖
20無水クエン酸
31
無水炭酸ナトリウム 19
香料・人工甘味料等 適量
この錠剤を水に投入すると激しく発泡して直ちに溶解し
、清涼飲料水が得られた。Anhydrous sodium citrate 30(%) glucose
20 Anhydrous citric acid
31 Anhydrous sodium carbonate 19 Flavoring, artificial sweeteners, etc. When an appropriate amount of this tablet was poured into water, it foamed violently and immediately dissolved, yielding a soft drink.
まだこの錠剤は、保存容器を開口して長期間放置しても
、錠剤の変形は全くみられなかった。This tablet did not show any deformation even if the storage container was left open for a long period of time.
実施例6
オレンジ飲料用錠剤
よく乾燥した下記の各成分を混合して打錠し、錠剤とし
だ。Example 6 Orange Beverage Tablet The following well-dried ingredients were mixed and compressed to form a tablet.
無水クエン酸ナトリウム 30(部)重炭酸ナ
トリウム 6
ショ糖 55
リンゴ酸 9カンキツ香
料および色素 適量
この錠剤を水に投入すると直ちに発泡しながら溶解し、
オレンジ飲料が得られた。Anhydrous sodium citrate 30 (parts) Sodium bicarbonate 6 Sucrose 55 Malic acid 9 Citrus flavor and color Appropriate amount When this tablet is poured into water, it immediately dissolves while foaming.
An orange drink was obtained.
また、この錠剤を、日中に入れて、しゃぶると、唾液に
て発泡崩壊し非常に爽快な感じが得られた。Also, when this tablet was taken during the day and sucked, the foam collapsed with saliva, giving a very refreshing feeling.
実施例7 水中使用農薬錠剤 次の各成分をよく混合し、打錠して錠剤を得だ。Example 7 Pesticide tablets for use in water The following ingredients were mixed well and compressed to obtain tablets.
農薬 40(%)
無水硫酸ソーダ 20
無水クエン酸 4
重炭酸ナトリウム 5
界面活性剤 5
坦体粉 26
別に、無水硫酸ナトリウムを除いた他は同じ組成の対照
錠剤試料を作った。Pesticide 40 (%) Anhydrous sodium sulfate 20 Anhydrous citric acid 4 Sodium bicarbonate 5 Surfactant 5 Carrier powder 26 Separately, control tablet samples with the same composition except for the anhydrous sodium sulfate were prepared.
これらを無包装で90日間放置の状態は次の様であった
。The conditions after leaving these without packaging for 90 days were as follows.
すなわち、本発明の錠剤は変化が認められす、水中に投
入すれば速やかに発泡溶解するに反し、対照品は、錠剤
が膨化したり破裂しており、水中に投入しても発泡崩壊
性が非常に劣っていた。In other words, the tablets of the present invention show a change in foaming and dissolving quickly when placed in water, whereas the tablets of the control product swell and burst, and do not foam and disintegrate even when placed in water. It was very inferior.
Claims (1)
質を、錠剤安定剤まだはその一部として使用することを
特徴とする発泡錠剤の製法。1. A method for producing effervescent tablets, characterized in that a hygroscopic but substantially non-deliquescent water-soluble substance is used as a tablet stabilizer or as a part thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP52097657A JPS585695B2 (en) | 1977-08-15 | 1977-08-15 | Manufacturing method of effervescent tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP52097657A JPS585695B2 (en) | 1977-08-15 | 1977-08-15 | Manufacturing method of effervescent tablets |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5444013A JPS5444013A (en) | 1979-04-07 |
JPS585695B2 true JPS585695B2 (en) | 1983-02-01 |
Family
ID=14198136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52097657A Expired JPS585695B2 (en) | 1977-08-15 | 1977-08-15 | Manufacturing method of effervescent tablets |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS585695B2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58177912A (en) * | 1982-04-12 | 1983-10-18 | Shiseido Co Ltd | Foamable bath agent |
JPS60166607A (en) * | 1984-02-08 | 1985-08-29 | Hara Sogyo Kk | Bath additive |
JPS61228100A (en) * | 1985-04-01 | 1986-10-11 | 株式会社ソフト九九コーポレーション | Foamable detergent composition |
JPS6233114A (en) * | 1985-08-05 | 1987-02-13 | Tomita Seiyaku Kk | Tableting method of foaming bath agent |
JPH07116017B2 (en) * | 1986-05-17 | 1995-12-13 | アース製薬株式会社 | Bath additive |
CA2110993C (en) * | 1992-04-10 | 2002-02-05 | Akihisa Takaichi | Food composition for inhibiting the formation of an intestinal putrefactive product |
JPH06327435A (en) * | 1992-11-10 | 1994-11-29 | Otsuka Pharmaceut Co Ltd | Nutrition-supplying composition |
GB2341798B (en) * | 1998-09-25 | 2001-03-14 | Brian Whittle Associates Ltd | Nutritional and pharmaceutical compositions comprising desiccants |
JP2001158703A (en) * | 1999-06-25 | 2001-06-12 | Ishihara Sangyo Kaisha Ltd | Water face-floating tablet agrochemical composition for paddy field, method for using the same and method for producing the same |
KR20020068081A (en) * | 2000-01-17 | 2002-08-24 | 교와 핫꼬 고교 가부시끼가이샤 | Bubbling tablet, bubbling bath additive tablet, bubbling washing detergent tablet, bubbling tablet for oral administration, and processes for producing these |
JP6075553B2 (en) * | 2013-06-25 | 2017-02-08 | 白元アース株式会社 | Foaming bath composition |
-
1977
- 1977-08-15 JP JP52097657A patent/JPS585695B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS5444013A (en) | 1979-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5387420A (en) | Morphine-containing efferverscent composition | |
US4508740A (en) | Tabletted beverage composition containing dipeptide sweetener and process therefore | |
CA1135190A (en) | Effervescent analgesic powder | |
US4093710A (en) | Rapid dissolving effervescent granules | |
US3082091A (en) | Effervescing composition in particle form | |
JPS62215536A (en) | Foamable couple, histamine h2 antagonist foamable composition containing same and manufacture | |
JPS61207322A (en) | Foamable solid composition containing ascorbic acid | |
JPS585695B2 (en) | Manufacturing method of effervescent tablets | |
KR102571340B1 (en) | Effervescent compositions containing co-crystals of the acid part | |
FI86799C (en) | Process for making foamable mixtures | |
EP0396972B1 (en) | An aqueous granulation solution and a method of tablet granulation | |
JPS5970610A (en) | Foaming bathing agent | |
JP2640108B2 (en) | Method for producing expandable granular material | |
KR100187951B1 (en) | Composition for foaming preparation | |
US4716046A (en) | Pulverulent water-soluble nonhygroscopic composition for preparing beverages with a lasting effervescence and method for preparing the same | |
JPH03227916A (en) | Foamable drug preparation composition | |
US3102075A (en) | Tableting process | |
JPS61243014A (en) | Foaming bath agent | |
JPS61192800A (en) | Production of foamable cleanser | |
JPH11189524A (en) | Bathing agent | |
MXPA02005534A (en) | Effervescent histamine h2. | |
JP3872730B2 (en) | Water quality modifier | |
KR900007309B1 (en) | Effervescent cleaner for bath | |
WO1986004599A1 (en) | Process for producing foaming composition | |
JPH0236115A (en) | Bathing agent |